The company has successfully provided over 2 billion doses worth of flip-top aluminium seals used for packaging COVID vaccines. The seal is used as a closure for injection vials during the vaccination drive and is as such an essential part of the vaccine package ensuring tamper-proof delivery. This is especially relevant for fulfilling India and the world’s current vaccination drive, especially given the need for successive booster doses considering the ever-changing nature of COVID.
KAISHA Packaging has been a constant and biggest supplier for these seals to all the vaccines available in the Indian market and abroad. To ensure a consistent supply of vaccines and plug any shortages or gaps, the company managed to arrange and stock an extremely large volume of raw material. Not only did KAISHA Packaging successfully manage this challenge, it also expanded its capacity by over 450 million pieces to reach the overall capacity of 1.2 billion pieces per annum over the past year, which was unprecedented.
Rishad Dadachanji, Director, KAISHA Group of Companies, said, “This is a testimonial of our commitment to support India’s vaccine drive and developers with the best packaging solutions. We are proud to have provided seals for over 2 billion vaccine doses so far. Under the current circumstances of ambiguity around the COVID pandemic, Kaisha is well-prepared to rise up to any supply challenges.”
KAISHA packaging was established as a premium manufacturer of pharmaceutical closure systems for vials as well as speciality plastics for pharmaceutical use in 2003. The company has since revolutionized the way that aluminium seals are manufactured in India.
Packaging 360 is a comprehensive knowledge sharing ecosystem for the Indian packaging industry. Our services include an online content platform to deliver news, insights and case studies; organising conferences seminars and customised training; Providing Bespoke Project Consulting, Market Research and Intelligence.
